A.D.A.M., Inc. Reports Financial Results for First Quarter 2006
biz.yahoo.com
Wednesday May 3, 7:30 am ET
Net Income of $0.07 Per Share, Healthcare Licensing Revenues Increase 18%
ATLANTA--(BUSINESS WIRE)--May 3, 2006--A.D.A.M., Inc. (Nasdaq:ADAM):
Financial and Operating Highlights:
Revenues for the quarter ended March 31, 2006 were $2,482,000 as compared to $2,338,000 in the year ago period. Revenues from healthcare licensing were $2,122,000 for the first quarter of 2006, an increase of 18% year over year attributable to the company's expanding customer licensing base. Revenues from education products and one-time sales were $360,000, a decrease of 33% from the year ago period. The decrease was primarily attributable to strong sales in 2005 of a new product after its initial release. Recurring revenues from healthcare licensing for the first quarter represented 85% of the company's total revenues, up from 77% from the year ago period.
Renewal rates for the company's licensing contracts for the first quarter ended March 31, 2006 was over 90%.
Net income increased 43% for the quarter ended March 31, 2006 to $728,000, or $0.07 per share on a fully diluted basis as compared to $508,000, or $0.06 per share on a fully diluted basis for the year ago period.
Operating margin for the quarter ended March 31, 2006, was 24%, an increase of 4% from 20% in the year ago period.
Proforma operating income, after removing non-cash stock-based compensation expenses, was $590,000 for the first quarter ended March 31, 2006, compared to $565,000 for the year ago period. Non-cash stock-based compensation expense primarily relates to variable compensation costs associated with options cancelled and re-issued in 1999 as well as the effects of the accounting treatment for incentive stock options granted to employees.
Cash and investments totaled $12,103,000 as of March 31, 2006, an increase of $1,426,000 from $10,677,000 as of December 31, 2005.
"Our core healthcare licensing revenues are increasing at a steady pace and we are pleased with the customer adoptions and strong renewal rates we continue to experience," said Kevin S. Noland, A.D.A.M.'s president and chief executive officer. "Our new product for education, A.D.A.M. Interactive Anatomy 4.0, was well received in the first quarter last year and sales continue to be strong, but were not anticipated to stay at last year's initial sales volume.
"We continue to be focused on the expansion of our initiatives into the consumer directed healthcare market," Noland continued. "During the first quarter, we introduced two key products, our health risk assessment reporting tools, and DecisionAssist, a library of tools that help consumers make informed choices about their use of healthcare services, such as whether to have a particular surgery, proceed with a test, or see a specialist. We believe that these types of tools, enhanced with A.D.A.M.'s consumer-friendly, interactive health content, speak directly to the growing needs of consumers as they take more control of their health decisions and cost of healthcare. We are excited by what we see happening in this marketplace, and believe that A.D.A.M. is well positioned to capitalize on its position as the trusted source of healthcare information and the emerging trends in consumer directed healthcare." |
